Back
Cassava Sciences Vs. EyePoint Pharmaceuticals Industry Stock Comparison
Sell
44
SAVA
Cassava Sciences
Last Price:
26.49
Seasonality Move:
47.33%
Buy
61
EYPT
EyePoint Pharmaceuticals
Last Price:
8.94
Seasonality Move:
28.93%
Sell
44
Cassava Sciences (SAVA)
is a Sell
Is Cassava Sciences a Buy, Sell or Hold?
- The current Cassava Sciences [SAVA] share price is $26.48. The Score for SAVA is 44, which is 12% below its historic median score of 50, and infers higher risk than normal.
- SAVA is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
61
EyePoint Pharmaceuticals (EYPT)
is a Buy
Is EyePoint Pharmaceuticals a Buy, Sell or Hold?
- The current EyePoint Pharmaceuticals [EYPT] share price is $8.95. The Score for EYPT is 61, which is 22% above its historic median score of 50, and infers lower risk than normal.
- EYPT is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
SAVA Stock Price Chart
What is Cassava Sciences's stock price today?
-
The Cassava Sciences share price today is $26.48
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SAVA is experiencing selling pressure, which indicates risk of future bearish movement.
EYPT Stock Price Chart
What is EyePoint Pharmaceuticals's stock price today?
-
The EyePoint Pharmaceuticals share price today is $8.95
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and EYPT is experiencing slight buying pressure.
SAVA Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.25 | Buy |
| Relative Strength Index (14 RSI): | 48.47 | Sell |
| Chaikin Money Flow: | -6063678 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (25.34 - 28.38) | Sell |
| Bollinger Bands (100): | (18.2 - 31.22) | Buy |
EYPT Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.37 | Sell |
| Relative Strength Index (14 RSI): | 41.34 | Sell |
| Chaikin Money Flow: | 378625 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (9.4 - 11.84) | Sell |
| Bollinger Bands (100): | (8.13 - 10.51) | Sell |
SAVA Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 27.36 | Sell |
| 20-day SMA: | 26.61 | Sell |
| 50-day SMA: | 27.53 | Sell |
| 200-day SMA: | 22.94 | Buy |
| 8-day EMA: | 27.63 | Sell |
| 20-day EMA: | 27.15 | Sell |
| 50-day EMA: | 26.83 | Sell |
| 200-day EMA: | 24.24 | Buy |
EYPT Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 9.31 | Sell |
| 20-day SMA: | 10.76 | Sell |
| 50-day SMA: | 9.77 | Sell |
| 200-day SMA: | 13.45 | Sell |
| 8-day EMA: | 9.35 | Sell |
| 20-day EMA: | 10.02 | Sell |
| 50-day EMA: | 9.94 | Sell |
| 200-day EMA: | 11.46 | Sell |
Cassava Sciences Earnings Growth & SAVA Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.98 per share, and an increase next year of $0.59 per share.
EyePoint Pharmaceuticals Earnings Growth & EYPT Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.09 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.31 per share, and a decrease next year of $0.31 per share.
Cassava Sciences Technical Analysis
| Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | Nov 22 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 11 | 12 | 13 | 14 | 15 | 18 | 19 | 20 | 21 | 22 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
EyePoint Pharmaceuticals Technical Analysis
| Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | Nov 22 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 11 | 12 | 13 | 14 | 15 | 18 | 19 | 20 | 21 | 22 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||